<?xml version="1.0" encoding="UTF-8"?>
<p>Ribavirin and Acyclovir are two drugs used during the earlier outbreaks of NiV in Malaysia and Singapore [
 <xref rid="B28-viruses-12-00465" ref-type="bibr">28</xref>,
 <xref rid="B62-viruses-12-00465" ref-type="bibr">62</xref>,
 <xref rid="B63-viruses-12-00465" ref-type="bibr">63</xref>]. Although Ribavirin reduced the death toll by 36% during the open label trial against Malaysian NiV outbreaks, subsequent studies in animal models failed to prove its efficacy [
 <xref rid="B64-viruses-12-00465" ref-type="bibr">64</xref>]. Favipiravir (T-705), a purine analogue inhibiting RNA-dependent RNA polymerase progressed to clinical trials for Ebola and various types of influenza antivirals have also shown efficacy against NiV in Syrian hamster animal models [
 <xref rid="B65-viruses-12-00465" ref-type="bibr">65</xref>,
 <xref rid="B66-viruses-12-00465" ref-type="bibr">66</xref>]. 
</p>
